According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General Meeting 2027 shall be composed of members appointed by the three largest shareholders, along with the Chairman of the Board of Directors.
The composition of the Nomination Committee has now been established, and Sedana Medical today announces that the Nomination Committee for the 2027 Annual General Meeting consists of:
The Nomination Committee together represents 35.54 percent of the voting rights for all voting shares in the company as of September 30, 2026. The Nomination Committee shall submit proposals for resolution by the 2027 General Meeting pertaining to the election of Chairman of the Meeting, fees and composition of the Board, auditors’ fees and the election of auditors and, if necessary, proposals for changes in the instruction to the Nomination Committee.
The Nomination Committee’s proposals will be presented in the Notice to the Annual General Meeting 2027 and on Sedana Medical’s website, www.sedanamedical.com.
Shareholders wishing to submit proposals to Sedana Medical’s Nomination Committee can do so by sending an e-mail to info@sedanamedical.com (subject “Nomination Committee”) or by letter posted to Sedana Medical AB (publ), Attn: Sedana Medical Nomination Committee, Svärdvägen 3A, SE-182 33, Danderyd, Sweden. A proposal must reach the Nomination Committee no later than April 9, 2027 to be included in the notice to attend and the agenda for the annual general meeting.